dehydroascorbic acid has been researched along with Colorectal Cancer in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asara, JM; Bosch, KN; Cantley, LC; Chen, Z; Chio, II; Dow, LE; Elemento, O; Giannopoulou, EG; Gross, SS; Kavalier, A; Lu, C; Muley, A; Mullarky, E; Paik, J; Papadopoulos, N; Pappin, DJ; Rago, C; Rivera, K; Roper, J; Yun, J | 1 |
| Abrantes, AM; Botelho, MF; Casalta-Lopes, JE; Gonçalves, AC; Maia, JM; Mamede, AC; Pires, AS; Sarmento-Ribeiro, AB; Tavares, SD | 1 |
2 other study(ies) available for dehydroascorbic acid and Colorectal Cancer
| Article | Year |
|---|---|
Vitamin C selectively kills KRAS and BRAF mutant colorectal cancer cells by targeting GAPDH.
Topics: Adenomatous Polyposis Coli Protein; Animals; Ascorbic Acid; Cell Line, Tumor; Colorectal Neoplasms; Dehydroascorbic Acid; Female; Glucose Transporter Type 1; Glyceraldehyde-3-Phosphate Dehydrogenase (Phosphorylating); Glycolysis; Humans; Mice; Mice, Mutant Strains; Mice, Nude; Proto-Oncogene Proteins; Proto-Oncogene Proteins B-raf; Proto-Oncogene Proteins p21(ras); ras Proteins; Reactive Oxygen Species; Xenograft Model Antitumor Assays | 2015 |
Cytotoxicity of ascorbic acid in a human colorectal adenocarcinoma cell line (WiDr): in vitro and in vivo studies.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Antioxidants; Ascorbic Acid; Cell Line, Tumor; Cell Proliferation; Cell Survival; Colorectal Neoplasms; Dehydroascorbic Acid; Flow Cytometry; Glutathione; Humans; Mice; Mice, Inbred BALB C; Mitochondrial Membranes; Spectrophotometry; Tumor Stem Cell Assay | 2012 |